跳至主要内容
临床试验/NCT01348581
NCT01348581已完成不适用

Chronic Wound Treatment With Extracellular Matrix (ECM) Scaffold Made From Fish Proteins

Kerecis Ltd.2 个研究点 分布在 1 个国家目标入组 37 人开始时间: 2010年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Kerecis Ltd.
入组人数
37
试验地点
2
主要终点
Wound healing

研究概览

简要总结

The clinical study is designed to assess the effectiveness, safety and non-immunogenicity of fish skin wound dressing extracellular matrix (ECM) in treating chronic wounds.

The wound dressing is indicated for the management of difficult to heal and chronic wounds. The matrix is cut to fit the wound and is applied to the wound bed. An absorptive secondary dressing is put on top. Further dressing of the wound depends on the etiology.

The indications for use are:

  • partial and full-thickness wounds
  • pressure ulcers
  • venous ulcers
  • diabetic ulcers
  • chronic vascular ulcers
  • tunneled/undermined wounds
  • trauma wounds (abrasions, lacerations, second-degree burns, and skin tears)

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Venous leg ulcer
  • Arterial leg ulcer
  • Rheumatic leg ulcer
  • Hydrostatic leg ulcer
  • Ulcer where healing is delayed because of drug therapy
  • Non-healing ulcer due to known or unknown causes

排除标准

  • Active infection

结局指标

主要结局

Wound healing

时间窗: one year

次要结局

  • Wound granulation(one year)

研究者

发起方
Kerecis Ltd.
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Use of Fish Skin Extracellular Matrix (ECM) to... | 临床试验